KPMG can help you improve the ROI on your sales investments - helping you manage winning sales strategies, processes, and talent with connected insights.
By Alex Tolmasoff, Director, KPMG Sales Transformation and HCLS Lead
Have you ever wondered what hospital leaders and providers think about when patient and provider volumes will return to “normal”?
Striking statistics from recent KPMG research indicate it won’t be soon:1
- 88%-89% providers believe there won’t be a return to pre-pandemic levels until the second half of 2023
- Over 40% of sites cut capital budgets in 2020, with more than 20% cutting operating budgets
The COVID-19 pandemic had an unprecedented effect on patients and healthcare providers; to understand the impact and aftereffects on healthcare organizations and how the front office (particularly the sales organization) must retool itself for this “new normal”, KPMG surveyed nearly 100 providers, including surgeons, primary care physicians, and hospital C-suite leaders in mid-2022. The survey set out to gauge provider perspectives in three key areas:
- Expectations on a return to normal, and how budgets have been impacted
- How technology will shape future operations in light of COVID impacts
- How vendor relationships will shift to accommodate new ways of working
In this - the first in a series of blogs exploring the survey findings – I concentrate on provider expectations related to:
- COVID-driven “return to normal” timing of patient and elective procedure volumes
- How leading providers are shifting capital and operating budgets to shorten that timeframe
- Common obstacles to a “return to normal” and strategies providers are using to overcome them